Dr Matthew Coleshill
Postdoctoral Fellow

Dr Matthew Coleshill

PhD (Psychology)

University of Hull, United Kingdom

Bachelor of Science (Honours) in Psychology

University of Hull, United Kingdom

Medicine & Health
The Black Dog Institute

My main research interests are the placebo and nocebo effects, particularly their influence on, and relationship to, treatment efficacy. Beyond this, I also have an interest in the variety of factors that contribute to the poor management of gout, particularly the relationship between illness perceptions and treatment adherence. At the moment I am working on the GAPP Trial, a randomised controlled trial examining the efficacy of a mobile application designed for people with gout in improving adherence to urate-lowering therapy.

Location
St Vincent's Clinical School, UNSW Medicine, UNSW Sydney Department of Clinical Pharmacology & Toxicology Therapeutics Centre, Level 2 Xavier Building St Vincent's Hospital Sydney Darlinghurst NSW 2010
  • Journal articles | 2023
    Coleshill MJ; Alagirisamy D; Patki S; Ronksley M; Black MJ; Yu S; Phillips M; Newby JM; Cockayne N; Tennant J; Harvey SB; Christensen H; Baldwin PA, 2023, 'The Essential Network (TEN): engagement and mental health insights from a digital mental health assessment tool for Australian health professionals during COVID-19', BMC Digital Health, 1, http://dx.doi.org/10.1186/s44247-023-00031-2
    Journal articles | 2023
    Kershaw KA; Storer B; Braund T; Chakouch C; Coleshill M; Haffar S; Harvey S; Newby J; Sicouri G; Murphy M, 2023, 'The prevalence of anxiety in adult endocrinology outpatients: A systematic review and meta–analysis', Psychoneuroendocrinology, pp. 106357 - 106357, http://dx.doi.org/10.1016/j.psyneuen.2023.106357
    Journal articles | 2023
    Spragg JCJ; Michael TJF; Aslani P; Coleshill MJ; Chan JS; Day RO; Stocker SL, 2023, 'Optimizing adherence to allopurinol for gout: patients' perspectives', British Journal of Clinical Pharmacology, 89, pp. 1978 - 1991, http://dx.doi.org/10.1111/bcp.15657
    Journal articles | 2023
    Storer B; Kershaw KA; Braund TA; Chakouch C; Coleshill MJ; Haffar S; Harvey S; Newby J; Sicouri G; Murphy M, 2023, 'The prevalence of anxiety disorders in dermatology outpatients: A systematic review and meta-analysis', Journal of the European Academy of Dermatology and Venereology, http://dx.doi.org/10.1111/jdv.19151
    Journal articles | 2023
    Storer B; Kershaw KA; Braund TA; Chakouch C; Coleshill MJ; Haffar S; Harvey S; Newby JM; Sicouri G; Murphy M, 2023, 'Global Prevalence of Anxiety in Adult Cardiology Outpatients: A Systematic Review and Meta-analysis', Current Problems in Cardiology, 48, pp. 101877, http://dx.doi.org/10.1016/j.cpcardiol.2023.101877
    Journal articles | 2023
    Wise S; Smith E; Carlos L; Coleshill M; Day RO; Melocco T; Carland JE, 2023, 'Who is asking? Requests for antimicrobial prescribing advice received by hospital pharmacists', Journal of Pharmacy Practice and Research, 53, pp. 39 - 43, http://dx.doi.org/10.1002/jppr.1841
    Journal articles | 2022
    Coleshill MJ; Baldwin P; Black M; Newby J; Shrestha T; Haffar S; Mills L; Stensel A; Cockayne N; Tennant J; Harvey S; Christensen H, 2022, 'The Essential Network (TEN): Protocol for an Implementation Study of a Digital-First Mental Health Solution for Australian Health Care Workers During COVID-19', JMIR Research Protocols, 11, pp. e34601, http://dx.doi.org/10.2196/34601
    Journal articles | 2022
    Coleshill MJ; Day RO; Tam K; Kouhkamari M; Caillet V; Aung E; Kannangara DRW; Cronin P; Rodgers A; Stocker SL, 2022, 'Persistence with urate-lowering therapy in Australia: A longitudinal analysis of allopurinol prescriptions', British Journal of Clinical Pharmacology, 88, pp. 4894 - 4901, http://dx.doi.org/10.1111/bcp.15435
    Journal articles | 2022
    Wise S; Coleshill MJ; Taylor N; Le M; Debono D; Day RO; Melocco T; Baysari MT; Laba TL; Carland JE, 2022, 'Australian hospital outpatient pharmacies: service adaptations during the 2020 national coronavirus disease 2019 lockdown', Journal of Pharmacy Practice and Research, 52, pp. 326 - 328, http://dx.doi.org/10.1002/jppr.1810
    Journal articles | 2021
    Coleshill MJ; Aung E; Carland JE; Faasse K; Stocker S; Day RO, 2021, 'Rebranding Gout: Could a Name Change for Gout Improve Adherence to Urate-Lowering Therapy?', Therapeutic Innovation and Regulatory Science, 55, pp. 138 - 141, http://dx.doi.org/10.1007/s43441-020-00198-0
    Journal articles | 2021
    Coleshill MJ; Sharpe L; Colagiuri B, 2021, 'No evidence that attentional bias towards pain-related words is associated with verbally induced nocebo hyperalgesia: A dot-probe study', Pain Reports, 6, http://dx.doi.org/10.1097/PR9.0000000000000921
    Journal articles | 2020
    Day R; Nguyen A; Graham G; Aung E; Coleshill M; Stocker S, 2020, 'Better outcomes for patients with gout', Inflammopharmacology, 28, pp. 1395 - 1400, http://dx.doi.org/10.1007/s10787-020-00694-7
    Journal articles | 2020
    Day RO; Coleshill MJ; Stocker SL; Nguyen AD; Robinson P; Aung E, 2020, 'Predictors of success in gout treatment', Journal of Rheumatology, 47, pp. 313 - 315, http://dx.doi.org/10.3899/jrheum.191150
    Journal articles | 2019
    Coleshill MJ; Aung E; Nguyen AD; Stocker SL; Baysari MT; Kamel B; Schulz M; McLachlan AJ; Day RO, 2019, 'Improving adherence to urate-lowering therapy in people living with gout', International Journal of Rheumatic Diseases, 22, pp. 542 - 544, http://dx.doi.org/10.1111/1756-185X.13566
    Journal articles | 2019
    Day RO; Cohen M; Coleshill MJ; Ghinea N; Lipworth W; Maher CG; Latimer J; Lin CWC; McLachlan AJ, 2019, 'Is it ethical to prescribe paracetamol for acute low back pain and osteoarthritis?', The Lancet Rheumatology, 1, pp. e140 - e142, http://dx.doi.org/10.1016/S2665-9913(19)30041-4
    Journal articles | 2019
    Day RO; Lau W; Stocker SL; Aung E; Coleshill MJ; Schulz M; Bechara J; Carland JE; Graham GG; Williams KM; McLachlan AJ, 2019, 'Management of gout in older people', Journal of Pharmacy Practice and Research, 49, pp. 90 - 97, http://dx.doi.org/10.1002/jppr.1511
    Journal articles | 2018
    Coleshill MJ; Sharpe L; Colloca L; Zachariae R; Colagiuri B, 2018, 'Placebo and Active Treatment Additivity in Placebo Analgesia: Research to Date and Future Directions', International Review of Neurobiology, 139, pp. 407 - 441, http://dx.doi.org/10.1016/bs.irn.2018.07.021
    Journal articles | 2017
    Coleshill MJ; George DN; Mazzoni G, 2017, 'Placebo Analgesia From a Rubber Hand', Journal of Pain, 18, pp. 1067 - 1077, http://dx.doi.org/10.1016/j.jpain.2017.04.004
  • Preprints | 2021
    Coleshill MJ; Baldwin P; Black M; Newby J; Shrestha T; Haffar S; Mills L; Stensel A; Cockayne N; Tennant J; Harvey S; Christensen H, 2021, The Essential Network (TEN): Protocol for an Implementation Study of a Digital-First Mental Health Solution for Australian Health Care Workers During COVID-19 (Preprint), , http://dx.doi.org/10.2196/preprints.34601
    Conference Papers | 2021
    Mao C; Coleshill M; Day RO; Aung E, 2021, 'ADHERENCE TO URATE LOWERING THERAPY AMONG PEOPLE WITH GOUT IN AUSTRALIA', in INTERNAL MEDICINE JOURNAL, WILEY, pp. 49 - 49, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000651518500135&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2020
    Aung E; Coleshill M; Schulz M; Kamel B; Stocker S; Day R, 2020, 'RECRUITING PEOPLE WITH GOUT INTO A CLINICAL TRIAL IN PRIMARY CARE: THE GAPP EXPERIENCE', in INTERNAL MEDICINE JOURNAL, WILEY, pp. 42 - 42, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000553988700116&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

 

 

2017       Society for Interdisciplinary Placebo Studies Travel Award (€300 EUR)

2016       Ian Potter Foundation Travel Grant ($1000 AUD)

2013       Experimental Psychology Society Grindley Grant (£500 GBP)

2011       University of Hull 80th Anniversary PhD Scholarship

Coleshill MJ; Aung E; Nguyen AD; Stocker SL; Baysari MT; Kamel B; Schulz M; McLachlan AJ; Day RO, 2019, 'Improving adherence to urate-lowering therapy in people living with gout', International Journal of Rheumatic Diseases, vol. 22, pp. 542 - 544, http://dx.doi.org/10.1111/1756-185X.13566, ROS ID: 1440067

Day RO; Lau W; Stocker SL; Aung E; Coleshill MJ; Schulz M; Bechara J; Carland JE; Graham GG; Williams KM; McLachlan AJ, 2019, 'Management of gout in older people', Journal of Pharmacy Practice and Research, vol. 49, pp. 90 - 97, http://dx.doi.org/10.1002/jppr.1511, ROS ID: 1418110

Coleshill MJ; Sharpe L; Colloca L; Zachariae R; Colagiuri B, 2018, 'Placebo and Active Treatment Additivity in Placebo Analgesia: Research to Date and Future Directions', International Review of Neurobiology, vol. 139, pp. 407 - 441, http://dx.doi.org/10.1016/bs.irn.2018.07.021, ROS ID: 1371886

Coleshill MJ; George DN; Mazzoni G, 2017, 'Placebo Analgesia From a Rubber Hand', Journal of Pain, vol. 18, pp. 1067 - 1077, http://dx.doi.org/10.1016/j.jpain.2017.04.004, ROS ID: 1383219

My Research Supervision

Medication adherence in people living with gout

Cultural perceptions of gout